Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
Conditions:   Solid Tumor;   Non Small Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck;   Urothelial Carcinoma
Interventions:   Drug: GEN-001;   Drug: Avelumab
Sponsors:   Genome & Company;   Merck KGaA, Darmstadt, Germany;   Pfizer
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 24, 2020 / by / in
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Conditions:   Ovarian Cancer;   Breast Cancer;   Solid Tumor;   Prostate Cancer;   Endometrial Cancer
Intervention:   Drug: CYH33
Sponsor:   ShangHai HaiHe Pharmaceutical
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 24, 2020 / by / in
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
Condition:   Soft Tissue Sarcoma
Interventions:   Drug: Talimogene Laherparepvec;   Radiation: Radiotherapy
Sponsors:   Varun Monga, MD;   Amgen
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Addressing Barriers to Palliative Care Use in Bladder Cancer
Conditions:   Muscle-Invasive Bladder Carcinoma;   Bladder Cancer Stage II;   Bladder Cancer Stage III;   Bladder Cancer Stage IV
Intervention:   Other: Surveys
Sponsor:   H. Lee Moffitt Cancer Center and Research Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction
Conditions:   Breast Cancer;   Mastectomy; Lymphedema;   Same Day Surgery;   Nipple-sparing Mastectomy;   Skin-sparing Mastectomy
Intervention:   Procedure: Same-day NSM or SSM
Sponsor:   Georgetown University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Conditions:   Melanoma;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck;   Urothelial Carcinoma;   Renal Cell Carcinoma;   Small-cell Lung Cancer;   Cutaneous Squamous Cell Carcinoma;   Anal Squamous Cell Carcinoma
Interventions:   Biological: GEN-011;   Drug: IL-2;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   Genocea Biosciences, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
A Trial Testing Chemo Mouthpiece Device and Best Supportive Care Against Best Supportive Care Only for Symptoms of Oral Mucositis in Patients Receiving Chemotherapy
Condition:   Oral Mucositis
Interventions:   Device: Chemo Mouthpiece;   Other: Best Supportive Care only
Sponsor:   Chemo Mouthpiece
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
Conditions:   Acute Leukemia;   Recurrent Leukemia;   Refractory Leukemia
Interventions:   Other: Best Practice;   Procedure: Bright White Light Therapy;   Other: Survey Administration
Sponsor:   Ohio State University Comprehensive Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention
Condition:   Prostate Cancer
Interventions:   Behavioral: Preferred music listening;   Behavioral: Relaxation breathing narrative over hypnotic music listening
Sponsor:   Johns Hopkins University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Diet Education Program for Stage I-IV Colorectal Cancer Survivors
Conditions:   Stage I Colorectal Cancer AJCC v8;   Stage II Colorectal Cancer AJCC v8;   Stage IIA Colorectal Cancer AJCC v8;   Stage IIB Colorectal Cancer AJCC v8;   Stage IIC Colorectal Cancer AJCC v8;   Stage III Colorectal Cancer AJCC v8;   Stage IIIA Colorectal Cancer AJCC v8;   Stage IIIB Colorectal Cancer AJCC v8;   Stage IIIC Colorectal Cancer AJCC v8;   Stage IV Colorectal Cancer AJCC v8;   Stage IVA Colorectal Cancer AJCC v8;   Stage IVB Colorectal Cancer AJCC v8;   Stage IVC Colorectal Cancer AJCC v8
Intervention:   Dietary Supplement: Dietary Intervention
Sponsor:   University of California, San Francisco
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in